Micropaque Ct

Barium sulfate, the active ingredient in Micropaque Ct, is a contrast media presented as an oral suspension for gastrointestinal radiography. It provides radiopaque contrast that delineates the esophagus, stomach, duodenum and large bowel during X‑ray examinations, facilitating accurate diagnostic imaging in patients. GNH USA supplies Micropaque Ct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets. We partner with accredited logistics providers to maintain product integrity during transport.

Micropaque Ct is a barium sulfate suspension used for radiographic imaging of the gastrointestinal tract.

- Barium swallow: enables clear visualization of the esophagus for assessment of motility and structural lesions. - Barium meal: outlines the stomach and duodenum to evaluate ulcer disease, tumors and anatomical abnormalities. - Barium enema: delineates the large bowel for detection of polyps, strictures, inflammation and perforation. - General gastrointestinal tract radiography: provides overall contrast for comprehensive GI studies.

Adverse reactions to Micropaque Ct are generally related to the gastrointestinal tract and occasional systemic responses.

Common Side Effects: - Nausea: mild to moderate discomfort after ingestion. - Abdominal cramping: transient pain during bowel transit. - Constipation: slowed bowel movements following the procedure. - Diarrhea: loose stools as the contrast moves through the intestines. - Metallic taste: temporary alteration in oral sensation. - Mild headache: occasional transient headache.

Serious or Rare Side Effects: - Barium impaction: blockage of the bowel requiring medical intervention. - Allergic reaction: rash, itching or urticaria indicating hypersensitivity. - Aspiration pneumonia: inhalation of the suspension leading to lung infection. - Perforation risk: exacerbated if a pre‑existing bowel wall defect is present. - Electrolyte imbalance: rare disturbances due to fluid shifts. - Severe abdominal pain: may signal complications such as obstruction or perforation.

Before using Micropaque Ct, clinicians should evaluate patient‑specific factors and follow handling guidelines to minimize risks.

- Assess for bowel obstruction: avoid use if obstruction is suspected. - Verify fasting status: administer after appropriate fasting period. - Review allergy history: contraindicated in known hypersensitivity to barium sulfate. - Ensure adequate hydration: encourage fluid intake after the study. - Use caution in pregnancy: limited data, weigh risk versus benefit. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Barium sulfate can interact with certain medications or substances that affect gastrointestinal imaging or patient safety.

Major Interactions (Avoid): - Tetracycline antibiotics: may cause false‑positive imaging artifacts. - Iron‑containing supplements: can produce radiopaque interference. - Potassium iodide: may alter contrast distribution. - Aluminum or magnesium antacids: can affect barium coating. - High‑dose vitamin C: may modify GI motility and contrast appearance.

Moderate Interactions (Monitor Closely): - Diuretics: risk of dehydration affecting contrast transit. - Laxatives: may accelerate bowel clearance, reducing image quality. - Antiemetics: can mask nausea related to the suspension. - Opioids: slow gastrointestinal motility, increasing retention time. - NSAIDs: may increase risk of GI irritation during the procedure.